Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · IEX Real-Time Price · USD
177.93
+0.73 (0.41%)
At close: Mar 28, 2024, 4:00 PM
182.15
+4.22 (2.37%)
After-hours: Mar 28, 2024, 7:15 PM EDT

Krystal Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
10.93-139.98-69.57-32.17-19.09-10.89-7.92-1.15
Depreciation & Amortization
5.012.641.851.851.090.140.020
Share-Based Compensation
39.9333.2315.323.271.240.790.250.03
Other Operating Activities
-144.683.534.460.96-1.930.513.76-0.2
Operating Cash Flow
-88.8-100.57-47.94-26.08-18.69-9.45-3.89-1.31
Capital Expenditures
88.2-52.98-68.34-14.84-6.4-2.23-0.21-0.02
Change in Investments
-5.56-61.1-158.433.661.41-8.0900
Investing Cash Flow
82.64-114.08-226.77-11.18-4.99-10.32-0.21-0.02
Share Issuance / Repurchase
203.536355.65118.02107.5373.8542.470.1
Debt Issued / Paid
00-7.960002.31.84
Other Financing Activities
-0.75-0.65----71.31
Financing Cash Flow
202.7535.35347.69118.02107.5373.8551.773.25
Exchange Rate Effect
-0.16-0.04000000
Net Cash Flow
196.43-179.3572.9880.7683.8454.0847.671.92
Free Cash Flow
-0.6-153.55-116.27-40.93-25.09-11.68-4.1-1.33
Free Cash Flow Margin
-1.19%-------
Free Cash Flow Per Share
-0.02-6.02-5.24-2.18-1.58-1.04-0.77-1.51
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).